BSR to deliver a 3-year national inflammatory arthritis audit to “make a significant difference to the lives of a million people living with inflammatory arthritis in England and Wales”
We’re pleased to announce that we have been awarded the contract to run the National Rheumatoid and Early Inflammatory Arthritis Audit.
The 3-year audit is commissioned by the Healthcare Quality Improvement Partnership (HQIP) as part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP). It will assess the care provided by rheumatology services in England and Wales and the health outcomes this achieves for people living with inflammatory arthritis conditions, including rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis. The performance of services will be assessed against NICE quality standards, measuring key items such as referral times from primary care, waiting time for specialised rheumatology care, time to treatment, access to education and self-management, and the outcome of care including disease remission.
Building on the previous audit that ran between 2014 and 2016, the new audit will provide more focused and precise data, helping reduce the burden on clinical teams, and will use an improved IT platform to streamline data collection and real-time feedback to support local quality improvement. To deliver this, we are partnering with Kings College Hospital, London who will provide statistical and epidemiological support and Netsolving, who will develop and run the IT platform.
Dr Peter Lanyon, BSR President said: ‘‘We are in a unique position as a rheumatology community to work with our members, maximise engagement with the national clinical audit, and embed a quality improvement culture that reduces variation and improves outcomes in every musculoskeletal service provider. Empowering our members with evidence of the impact and value of the care that they provide is a key part of our new strategy, and provides us with an invaluable opportunity to make a significant difference to the lives of almost a million people living with inflammatory arthritis in England and Wales.”
Over the next few months, we will work on developing and testing the data collection tools and processes, with a view to launching data collection for the national clinical audit from April 2018, with first reports likely in the autumn of 2019.